Earnings Call · Q3 FY2023·2023-08-14

Q3 23EPS +2.44%·Rev n/aQ2 23EPS -2.44%·Rev n/aQ1 23EPS 0.00%·Rev n/aQ4 22EPS +18.18%·Rev n/a⚠ consensus missing

NEUROONE MEDICAL TECHNOLOGIES Corp NMTC

Dave Rosa — Chief Executive Officer

Ron McClurg — Chief Financial Officer

−3.8%1d on move date−2.6% vs SPY3d−6.5%5d−5.6%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more NMTC calls or request research access.

More NMTC calls Browse calls Request research access